Research Article

A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease

Table 1

A list of bioactive compounds of EZP for network analysis.

Mol IDMolecule nameMWOB (%)DLPubchem IDHerb

MOL000006Luteolin286.2536.160.255280445LLF/EH
MOL000098Quercetin302.2546.430.285280343LLF/EH
MOL000263Oleanolic acid456.7829.020.7610494LLF
MOL000358Beta-sitosterol414.7936.910.75222284LLF
MOL000422Kaempferol286.2541.880.245280863LLF
MOL002929Salidroside300.347.010.20159278LLF
MOL004576Taxifolin304.2757.840.27439533LLF
MOL005146Lucidumoside D568.6348.870.7110531060LLF
MOL005147Lucidumoside D_qt406.4754.410.47LLF
MOL005169(20S)-24-ene-3β,20-diol-3-acetate486.8640.230.82185500LLF
MOL005188Specnuezhenide686.7319.300.5091895359LLF
MOL005190Eriodictyol288.2771.790.24440735LLF
MOL005195Syringaresinol diglucoside_qt450.4883.120.821603207LLF
MOL005209Lucidusculine401.630.110.75101286217LLF
MOL005211Olitoriside696.8765.450.2394348LLF
MOL005212Olitoriside_qt404.55103.230.78LLF
MOL001689Acacetin284.2834.970.245280442EH
MOL001790Linarin592.639.840.715317025EH
MOL002975Butin272.2769.940.2128125525EH
MOL0033893-O-Methylorobol300.2857.410.275489605EH
MOL003398Pratensein299.2739.060.285319744EH
MOL003402Demethylwedelolactone302.2572.130.435281803EH
MOL003404Wedelolactone314.2649.60.485281813EH